Families Filming Infants Learning Movement

The study objective is to improve accuracy in the early detection of neurodevelopmental impairment, especially CP, by evaluating the timepoint (in weeks post term age) that the Prechtl GMA is most useful for prediction of neurodevelopmental impairment at two years of age in children with and without medical complexity. The study team plans to recruit 100 healthy, term-born infants and 250 infants at risk of developing CP for a total of 350 enrolled infants.

NCT Number	NCT06278961
Lead Sponsor	Ann & Robert H Lurie Children's Hospital of Chicago Collaborators: Northwestern University, IRCCS Fondazione Stella Maris, University of Melbourne, University of Sydney
Conditions	Infant Development, Cerebral Palsy, Motor Disorders, Neurological Disorder
Enrollment	350 participants
Start Date	2021-01-28
Primary Completion	2026-09-30 (estimated)
Study Completion	2026-09-30 (estimated)
Updated on ClinicalTrials.gov	2025-02-13